BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
24 mai 2024 16h30 HE
|
BIO-key International, Inc.
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq regarding untimely filing of its form 10-Q.
BIO-key Expects to File Audited 2023 Results on Form 10-K and Report Q1 2024 Results and Host an Investor Call Next Week
16 mai 2024 16h55 HE
|
BIO-key International, Inc.
BIO-key Expects to File Audited 2023 Results on Form 10-K & Report Q1’24 Results with an Investor Call Next Week.
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
23 avr. 2024 16h05 HE
|
Trxade Health, Inc.
TAMPA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (Nasdaq: MEDS) (the “Company”), announced that, on April 17, 2024, the Company received a notice (the “Notice”) from the Nasdaq...
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
22 avr. 2024 16h30 HE
|
BIO-key International, Inc.
BIO-key International, Inc. Received Notice of Non-Compliance from Nasdaq regarding filing all required periodic financial reports with the SEC.
BIO-key Regains Compliance with Nasdaq Rule Requiring Timely Filing of Periodic Financial Reports Following Filing of its Q1’23 Form 10-Q with SEC
13 juin 2023 13h12 HE
|
BIO-key International, Inc.
WALL, N.J., June 13, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring...
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
30 mai 2023 16h33 HE
|
BIO-key International, Inc.
WALL, N.J., May 30, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring...
BiondVax Files FY 2022 Financial Statements and Annual Report on Form 10-K and Provides Business Update
17 avr. 2023 16h25 HE
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, April 17, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing...
InnerScope Hearing Technologies (OTC: INND) Completes its 2019 & 2020 Audited Financial Statements
14 sept. 2022 10h23 HE
|
InnerScope Hearing Technologies, Inc.
ROSEVILLE, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging and disruptive leader in the Direct-to-Consumer...
Boon Industries Announces Filing of Annual Report on Form 10-K with the Securities and Exchange Commission
03 mai 2022 08h00 HE
|
Boon Industries Inc.
SACRAMENTO, CA, May 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Boon Industries, Inc. (OTC PINK: BNOW) (“Boon” or the “Company”), an innovative bioscience company delivering solutions that...
AMMO, Inc. Announces $51 Million Revenue Projection for Fiscal Second Quarter 2022
15 juil. 2021 08h30 HE
|
AMMO, Inc.
SCOTTSDALE, AZ, July 15, 2021 (GLOBE NEWSWIRE) -- AMMO, Inc. (Nasdaq: POWW & POWWP) (“AMMO” or the “Company”), a leading vertically integrated producer of high-performance ammunition and...